Long-Term Gains with Austedo in Tardive Dyskinesia

(MedPage Today) -- Deutetrabenazine (Austedo) showed maintained efficacy for tardive dyskinesia (TD) symptoms over a 3-year period, researchers reported.
In an open-label extension study of two 12-week clinical trials, 73% patients on deutetrabenazine...